↓ Skip to main content

Long-Term Safety of Intravenous Ibandronic Acid for Up to 4 Years in Metastatic Breast Cancer

Overview of attention for article published in Clinical Drug Investigation, September 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

policy
2 policy sources

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
52 Mendeley
Title
Long-Term Safety of Intravenous Ibandronic Acid for Up to 4 Years in Metastatic Breast Cancer
Published in
Clinical Drug Investigation, September 2012
DOI 10.2165/00044011-200626060-00002
Pubmed ID
Authors

Martin Pecherstorfer, Saul Rivkin, Jean-Jacques Body, Ingo Diel, Bengt Bergström

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Ecuador 1 2%
Unknown 50 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 17%
Researcher 6 12%
Other 6 12%
Student > Ph. D. Student 5 10%
Student > Bachelor 4 8%
Other 10 19%
Unknown 12 23%
Readers by discipline Count As %
Medicine and Dentistry 19 37%
Pharmacology, Toxicology and Pharmaceutical Science 4 8%
Agricultural and Biological Sciences 4 8%
Nursing and Health Professions 3 6%
Decision Sciences 2 4%
Other 6 12%
Unknown 14 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2012.
All research outputs
#5,446,629
of 25,373,627 outputs
Outputs from Clinical Drug Investigation
#172
of 1,035 outputs
Outputs of similar age
#39,054
of 189,082 outputs
Outputs of similar age from Clinical Drug Investigation
#48
of 390 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,035 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 189,082 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 390 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.